PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31730733-6	2020	Since an epidermal growth factor receptor mutation was identified by analysis of the exfoliated tumour cells in pleural effusion, erlotinib was administered, without further treatment of the membranous nephropathy.	erlotinib	130-139	epidermal growth factor receptor	Homo sapiens	9-41	
31730733-8	2020	WHAT IS NEW AND CONCLUSION: For patients with EGFR-mutation-positive lung adenocarcinoma associated with paraneoplastic membranous nephropathy, erlotinib might serve as a treatment option for both the tumour and the membranous nephropathy.	erlotinib	144-153	epidermal growth factor receptor	Homo sapiens	46-50